Innovative Sphingolipid Modulators for Multiple Sclerosis Treatment
The new modulators of sphingolipid signaling enable the treatment of relapsing-remitting multiple sclerosis.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
